Home
|
Press
|
Events
|
Eshare
Sign in
/
Register
0
Shopping Cart
X
Close
My Products (0 items)
My shopping cart is empty.
.
Sign in
/
Register
X
Close
Login/Register
Email
Password
INDUSTRIES
Agriculture
Chemicals
Food & Feed
Pesticides
Titanium Dioxide (TiO2)
Dairy Products
Full Industry List
ONLINE DATABASE
PRODUCTS & SERVICE
Products' Introduction
Industrial Reports
Newsletters
Market Data
Content Byte
Agrochemical Regulatory
Customized solutions
IMPACT FACTOR
MARKET NEWS
Agriculture
Chemicals
Food & Feed
Other
ABOUT
About CCM
Why CCM?
CCM Story
CCM Clients
Events
Career
Company news
CONTACT
Home
Product
Newsletters
>
受益主营产品价格上涨,和邦生物上半年净利润预增近2倍
Read online
受益主营产品价格上涨,和邦生物上半年净利润预增近2倍
7月13日,四川和邦生物科技股份有限公司(和邦生物)披露了2022年半年度业绩预告,预计2022年上半年度实现归母净利同比增加168,572.63万(25,211.65万美元)~188,572.63万元(28,202.84万美元),同比增加 184.38%~206.25%。谈及业绩增长原因,和邦生物表示,2022年上半年,公司主要产品双甘膦、草甘膦和氯化铵得益于下游农业应用需求增长,纯碱得益于下游新能源产业的光伏玻璃、碳酸锂应用需求增长,产品销售价格较去年同期有较大提升。
Herbicides China Monthly Report 202207 (Chinese Version)
Add to DIY report
Select whole article
I haven't create reports,
create a new report
right now!
Recommend Newsletters
Crop Farming in China
2016/05/31
More>>
Report on Glyphosate Business Opportunities Worldwide
2016/07/27
More>>
Specialised Control and Prevention of Pests and Diseases for Crops in China
2016/07/12
More>>
Loading...